Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
0.4813
-0.0351 (-6.80%)
At close: May 22, 2026, 4:00 PM EDT
0.4670
-0.0143 (-2.97%)
After-hours: May 22, 2026, 7:59 PM EDT
Sunshine Biopharma Revenue
Sunshine Biopharma had revenue of $8.09M in the quarter ending March 31, 2026, a decrease of -9.13%. This brings the company's revenue in the last twelve months to $35.49M, down -2.05% year-over-year. In the year 2025, Sunshine Biopharma had annual revenue of $36.31M with 4.11% growth.
Revenue (ttm)
$35.49M
Revenue Growth
-2.05%
P/S Ratio
0.07
Revenue / Employee
$709,866
Employees
50
Market Cap
2.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 36.31M | 1.43M | 4.11% |
| Dec 31, 2024 | 34.87M | 10.78M | 44.75% |
| Dec 31, 2023 | 24.09M | 19.75M | 454.42% |
| Dec 31, 2022 | 4.35M | 4.12M | 1,802.41% |
| Dec 31, 2021 | 228.43K | 157.02K | 219.88% |
| Dec 31, 2020 | 71.41K | 50.29K | 238.10% |
| Dec 31, 2019 | 21.12K | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 1.71K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Jul 31, 2009 | - | - | - |
| Jul 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IM Cannabis | 36.47M |
| cbdMD | 19.98M |
| Universe Pharmaceuticals INC | 17.86M |
| Sonoma Pharmaceuticals | 17.72M |
| InMed Pharmaceuticals | 4.94M |
| Akanda | 836.66K |
| RedHill Biopharma | 286.00K |
| Gelteq | 270.85K |
SBFM News
- 2 days ago - Sunshine announces approval of generic amoxicillin formulation for Canada - TheFly
- 2 days ago - Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin - Accesswire
- 4 days ago - 3 Penny Stocks to Watch Now, 5/19/26 - TipRanks
- 4 days ago - Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering - Accesswire
- 5 days ago - Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering - Accesswire
- 5 days ago - Why Is Penny Stock Sunshine Biopharma (SBFM) Up Today? - TipRanks
- 11 days ago - Sunshine Biopharma files to sell 5.825M common units - TheFly
- 6 weeks ago - Sunshine Biopharma reports FY25 EPS ($1.44) vs. ($7.32) last year - TheFly